Related Experiment Videos
Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease
Mehmet Cakir1, Osman Cekiç, O Faruk Yilmaz
1Beyoğlu Eye Training and Research Hospital, Istanbul, Turkey.
An 11-year-old girl with active subfoveal choroidal neovascularization associated with Best disease responded well to a single intravitreal injection of combined bevacizumab and triamcinolone acetonide. Choroidal neovascularization regressed, subretinal serous fluid resorbed, and visual acuity improved from 20/400 to 20/100. The patient remained stable for 6 months after injection.
An 11-year-old girl with active subfoveal choroidal neovascularization associated with Best disease responded well to a single intravitreal injection of combined bevacizumab and triamcinolone acetonide. Choroidal neovascularization regressed, subretinal serous fluid resorbed, and visual acuity improved from 20/400 to 20/100. The patient remained stable for 6 months after injection.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Diabetic Retinopathy